Mitochondria-related chemoradiotherapy resistance genes-based machine learning model associated with immune cell infiltration on the prognosis of esophageal cancer and its value in pan-cancer
Esophageal cancer, known for its high incidence and low five-year survival rate, poses significant treatment challenges. A key aspect of this challenge is the close link between mitochondria and resistance to chemoradiotherapy (CRT). Currently, there is a scarcity of biomarkers for predicting CRT re...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523324000226 |
_version_ | 1797322461509844992 |
---|---|
author | Ziyu Liu Zahra Zeinalzadeh Tao Huang Yingying Han Lushan Peng Dan Wang Zongjiang Zhou DIABATE Ousmane Junpu Wang |
author_facet | Ziyu Liu Zahra Zeinalzadeh Tao Huang Yingying Han Lushan Peng Dan Wang Zongjiang Zhou DIABATE Ousmane Junpu Wang |
author_sort | Ziyu Liu |
collection | DOAJ |
description | Esophageal cancer, known for its high incidence and low five-year survival rate, poses significant treatment challenges. A key aspect of this challenge is the close link between mitochondria and resistance to chemoradiotherapy (CRT). Currently, there is a scarcity of biomarkers for predicting CRT response and prognosis in esophageal cancer. Our study addresses this gap by developing a prognostic model that incorporates mitochondria-related CRT resistance (MRCRTR) genes, including CTSL, TBL1X, CLN8, MMP1, PDPN, and MRPL37. Survival analysis using Kaplan–Meier curves reveals that patients with high MRCRTR scores have lower survival rates than those with low scores. Utilizing a nomogram, we successfully predict the one-, two-, and three-year overall survival rates for esophageal cancer patients. Cox regression analysis confirms the MRCRTR score as an independent prognostic factor. Furthermore, our single-cell and correlation analyses suggested that MRCRTR genes might influence CRT resistance by modulating the immune microenvironment and impacting angiogenesis. Our pan-cancer analysis also indicates the potential applicability of MRCRTR scores to head and neck squamous cell carcinoma. The validation of these findings, conducted with samples from Xiang-ya Hospital, aligns closely with our bioinformatics results. Our study not only explores the role of MRCRTR genes in predicting the prognosis of esophageal cancer but also enhances the understanding of the interplay between CRT, mitochondria, and patient outcomes. |
first_indexed | 2024-03-08T05:14:41Z |
format | Article |
id | doaj.art-fbf253c1c4c34ce59eacd58db8e52ddd |
institution | Directory Open Access Journal |
issn | 1936-5233 |
language | English |
last_indexed | 2024-03-08T05:14:41Z |
publishDate | 2024-04-01 |
publisher | Elsevier |
record_format | Article |
series | Translational Oncology |
spelling | doaj.art-fbf253c1c4c34ce59eacd58db8e52ddd2024-02-07T04:44:27ZengElsevierTranslational Oncology1936-52332024-04-0142101896Mitochondria-related chemoradiotherapy resistance genes-based machine learning model associated with immune cell infiltration on the prognosis of esophageal cancer and its value in pan-cancerZiyu Liu0Zahra Zeinalzadeh1Tao Huang2Yingying Han3Lushan Peng4Dan Wang5Zongjiang Zhou6DIABATE Ousmane7Junpu Wang8Department of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China; Department of Pathology, School of Basic Medicine, Central South University, Changsha City, Hunan Province, China; Ultrapathology (Biomedical Electron Microscopy) Center, Department of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China; Key Laboratory of Hunan Province in Neurodegenerative Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China; Department of Pathology, School of Basic Medicine, Central South University, Changsha City, Hunan Province, ChinaDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China; Department of Pathology, School of Basic Medicine, Central South University, Changsha City, Hunan Province, ChinaDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China; Department of Pathology, School of Basic Medicine, Central South University, Changsha City, Hunan Province, ChinaDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China; Department of Pathology, School of Basic Medicine, Central South University, Changsha City, Hunan Province, ChinaDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China; Department of Pathology, School of Basic Medicine, Central South University, Changsha City, Hunan Province, ChinaDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China; Department of Pathology, School of Basic Medicine, Central South University, Changsha City, Hunan Province, ChinaDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China; Department of Pathology, School of Basic Medicine, Central South University, Changsha City, Hunan Province, ChinaDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China; Department of Pathology, School of Basic Medicine, Central South University, Changsha City, Hunan Province, China; Ultrapathology (Biomedical Electron Microscopy) Center, Department of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China; Key Laboratory of Hunan Province in Neurodegenerative Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China; Corresponding author at: Department of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China.Esophageal cancer, known for its high incidence and low five-year survival rate, poses significant treatment challenges. A key aspect of this challenge is the close link between mitochondria and resistance to chemoradiotherapy (CRT). Currently, there is a scarcity of biomarkers for predicting CRT response and prognosis in esophageal cancer. Our study addresses this gap by developing a prognostic model that incorporates mitochondria-related CRT resistance (MRCRTR) genes, including CTSL, TBL1X, CLN8, MMP1, PDPN, and MRPL37. Survival analysis using Kaplan–Meier curves reveals that patients with high MRCRTR scores have lower survival rates than those with low scores. Utilizing a nomogram, we successfully predict the one-, two-, and three-year overall survival rates for esophageal cancer patients. Cox regression analysis confirms the MRCRTR score as an independent prognostic factor. Furthermore, our single-cell and correlation analyses suggested that MRCRTR genes might influence CRT resistance by modulating the immune microenvironment and impacting angiogenesis. Our pan-cancer analysis also indicates the potential applicability of MRCRTR scores to head and neck squamous cell carcinoma. The validation of these findings, conducted with samples from Xiang-ya Hospital, aligns closely with our bioinformatics results. Our study not only explores the role of MRCRTR genes in predicting the prognosis of esophageal cancer but also enhances the understanding of the interplay between CRT, mitochondria, and patient outcomes.http://www.sciencedirect.com/science/article/pii/S1936523324000226Chemoradiotherapy resistanceMitochondria-related genesEsophageal CancerMachine Learning ModelsCTSL |
spellingShingle | Ziyu Liu Zahra Zeinalzadeh Tao Huang Yingying Han Lushan Peng Dan Wang Zongjiang Zhou DIABATE Ousmane Junpu Wang Mitochondria-related chemoradiotherapy resistance genes-based machine learning model associated with immune cell infiltration on the prognosis of esophageal cancer and its value in pan-cancer Translational Oncology Chemoradiotherapy resistance Mitochondria-related genes Esophageal Cancer Machine Learning Models CTSL |
title | Mitochondria-related chemoradiotherapy resistance genes-based machine learning model associated with immune cell infiltration on the prognosis of esophageal cancer and its value in pan-cancer |
title_full | Mitochondria-related chemoradiotherapy resistance genes-based machine learning model associated with immune cell infiltration on the prognosis of esophageal cancer and its value in pan-cancer |
title_fullStr | Mitochondria-related chemoradiotherapy resistance genes-based machine learning model associated with immune cell infiltration on the prognosis of esophageal cancer and its value in pan-cancer |
title_full_unstemmed | Mitochondria-related chemoradiotherapy resistance genes-based machine learning model associated with immune cell infiltration on the prognosis of esophageal cancer and its value in pan-cancer |
title_short | Mitochondria-related chemoradiotherapy resistance genes-based machine learning model associated with immune cell infiltration on the prognosis of esophageal cancer and its value in pan-cancer |
title_sort | mitochondria related chemoradiotherapy resistance genes based machine learning model associated with immune cell infiltration on the prognosis of esophageal cancer and its value in pan cancer |
topic | Chemoradiotherapy resistance Mitochondria-related genes Esophageal Cancer Machine Learning Models CTSL |
url | http://www.sciencedirect.com/science/article/pii/S1936523324000226 |
work_keys_str_mv | AT ziyuliu mitochondriarelatedchemoradiotherapyresistancegenesbasedmachinelearningmodelassociatedwithimmunecellinfiltrationontheprognosisofesophagealcanceranditsvalueinpancancer AT zahrazeinalzadeh mitochondriarelatedchemoradiotherapyresistancegenesbasedmachinelearningmodelassociatedwithimmunecellinfiltrationontheprognosisofesophagealcanceranditsvalueinpancancer AT taohuang mitochondriarelatedchemoradiotherapyresistancegenesbasedmachinelearningmodelassociatedwithimmunecellinfiltrationontheprognosisofesophagealcanceranditsvalueinpancancer AT yingyinghan mitochondriarelatedchemoradiotherapyresistancegenesbasedmachinelearningmodelassociatedwithimmunecellinfiltrationontheprognosisofesophagealcanceranditsvalueinpancancer AT lushanpeng mitochondriarelatedchemoradiotherapyresistancegenesbasedmachinelearningmodelassociatedwithimmunecellinfiltrationontheprognosisofesophagealcanceranditsvalueinpancancer AT danwang mitochondriarelatedchemoradiotherapyresistancegenesbasedmachinelearningmodelassociatedwithimmunecellinfiltrationontheprognosisofesophagealcanceranditsvalueinpancancer AT zongjiangzhou mitochondriarelatedchemoradiotherapyresistancegenesbasedmachinelearningmodelassociatedwithimmunecellinfiltrationontheprognosisofesophagealcanceranditsvalueinpancancer AT diabateousmane mitochondriarelatedchemoradiotherapyresistancegenesbasedmachinelearningmodelassociatedwithimmunecellinfiltrationontheprognosisofesophagealcanceranditsvalueinpancancer AT junpuwang mitochondriarelatedchemoradiotherapyresistancegenesbasedmachinelearningmodelassociatedwithimmunecellinfiltrationontheprognosisofesophagealcanceranditsvalueinpancancer |